Regulation of axotomy-induced dopaminergic neuron death and c-Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase
- PMID: 16336220
- DOI: 10.1111/j.1471-4159.2005.03568.x
Regulation of axotomy-induced dopaminergic neuron death and c-Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase
Abstract
Mechanical transection of the nigrostriatal dopamine pathway at the medial forebrain bundle (MFB) results in the delayed degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc). We have previously demonstrated that c-Jun activation is an obligate component of neuronal death in this model. Here we identified the small GTPase, cdc42, and mixed lineage kinases (MLKs) as upstream factors regulating neuronal loss and activation of c-Jun following MFB axotomy. Adenovirus-mediated expression of a dominant-negative form of cdc42 in nigral neurons blocked MFB axotomy-induced activation (phosphorylation) of MAP kinase kinase 4 (MKK4) and c-Jun, resulting in attenuation of SNpc neuronal death. Pharmacological inhibition of MLKs, MKK4-activating kinases, significantly reduced the phosphorylation of c-Jun and abrogated dopaminergic neuronal degeneration following MFB axotomy. Taken together, these findings suggest that death of nigral dopaminergic neurons following axotomy can be attenuated by targeting cell signaling events upstream of c-Jun N-terminal mitogen-activated protein kinase/c-Jun.
Similar articles
-
Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylation and activation transcription factor 3 expression.Exp Neurol. 2008 Jan;209(1):268-78. doi: 10.1016/j.expneurol.2007.09.033. Epub 2007 Oct 13. Exp Neurol. 2008. PMID: 18036593
-
Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor.Eur J Neurosci. 2001 Jan;13(1):1-14. Eur J Neurosci. 2001. PMID: 11134999
-
Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats.Exp Neurol. 2004 Sep;189(1):189-96. doi: 10.1016/j.expneurol.2004.05.028. Exp Neurol. 2004. PMID: 15296849
-
Activation of the c-Jun transcription factor following neurodegeneration in vivo.Neurosci Lett. 2004 May 6;361(1-3):36-9. doi: 10.1016/j.neulet.2003.12.011. Neurosci Lett. 2004. PMID: 15135887 Review.
-
Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease.Mov Disord. 2005 Jun;20(6):653-64. doi: 10.1002/mds.20390. Mov Disord. 2005. PMID: 15719422 Review.
Cited by
-
Activation of c-Jun N-terminal kinase (JNK) during mitosis in retinal progenitor cells.PLoS One. 2012;7(4):e34483. doi: 10.1371/journal.pone.0034483. Epub 2012 Apr 4. PLoS One. 2012. PMID: 22496813 Free PMC article.
-
Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease.Ann Clin Transl Neurol. 2022 Sep;9(9):1428-1436. doi: 10.1002/acn3.51643. Epub 2022 Aug 17. Ann Clin Transl Neurol. 2022. PMID: 35976992 Free PMC article.
-
Role of transcription factors in peripheral nerve regeneration.Front Mol Neurosci. 2012 Feb 10;5:8. doi: 10.3389/fnmol.2012.00008. eCollection 2012. Front Mol Neurosci. 2012. PMID: 22363260 Free PMC article.
-
Apoptotic cell death regulation in neurons.FEBS J. 2019 Sep;286(17):3276-3298. doi: 10.1111/febs.14970. Epub 2019 Jul 12. FEBS J. 2019. PMID: 31230407 Free PMC article. Review.
-
Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease.Pharmacol Ther. 2007 Jun;114(3):261-77. doi: 10.1016/j.pharmthera.2007.02.002. Epub 2007 Feb 27. Pharmacol Ther. 2007. PMID: 17399794 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous